Paradigm Asset Management CO LLC Amgen Inc Transaction History

Paradigm Asset Management CO LLC

$248 Million
Q4 2024

A detailed history of Paradigm Asset Management CO LLC transactions in Amgen Inc stock. As of the latest transaction made, Paradigm Asset Management CO LLC holds 900 shares of AMGN stock, worth $277,029. This represents 0.09% of its overall portfolio holdings.

Number of Shares

900

Previous 5,700 84.21%

Holding current value

$277,029

Previous $1.84 Million 87.25%

% of portfolio

0.09%

Previous 0.69%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	SELL	$258.78 - $328.31 $1.24 Million - $1.58 Million	-4,800 Reduced 84.21%	900 $234,000
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $420,400 - $510,896	-1,600 Reduced 21.92%	5,700 $1.78 Million
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $51,140 - $57,691	-200 Reduced 2.67%	7,300 $2.1 Million
Q3 2023 Oct 31, 2023	SELL	$218.65 - $271.46 $87,460 - $108,583	-400 Reduced 5.06%	7,500 $2.02 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $192,843 - $228,033	-900 Reduced 10.23%	7,900 $1.75 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $1.76 Million - $2.24 Million	7,700 Added 700.0%	8,800 $2.31 Million
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $44,892 - $50,630	-200 Reduced 15.38%	1,100 $248 Million
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $299,923 - $333,762	1,300 New	1,300 $316,000
Q2 2020 Aug 11, 2020	SELL	$197.81 - $242.74 $158,248 - $194,192	-800 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $45,560 - $60,425	250 Added 45.45%	800 $162,000
Q2 2019 Aug 08, 2019	SELL	$166.7 - $195.41 $300,060 - $351,738	-1,800 Reduced 76.6%	550 $0
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $9,043 - $10,194	-50 Reduced 2.08%	2,350 $0
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $71,360 - $83,300	400 Added 20.0%	2,400 $467,000
Q3 2018 Nov 19, 2018	SELL	$185.29 - $208.89 $37,058 - $41,778	-200 Reduced 9.09%	2,000 $0
Q1 2018 May 07, 2018	SELL	$169.43 - $198.0 $16,943 - $19,800	-100 Reduced 4.35%	2,200 $0
Q4 2017 Feb 12, 2018	SELL	$168.79 - $188.59 $50,637 - $56,577	-300 Reduced 11.54%	2,300 $0
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $434,954 - $496,600	2,600	2,600 $0

Others Institutions Holding AMGN

# of Institutions

3,087

Shares Held

402M

Call Options Held

7.57M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Asset Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Asset Management CO LLC with notifications on news.

Account

Paradigm Asset Management CO LLC Amgen Inc Transaction History